Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

Request To Download Free Sample of This Strategic Report@ The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

For stroke patients undergoing mechanical thrombectomy, adjunctive intra-arterial thrombolytics fell short for further ...

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research ...

Wells Fargo & Company reaffirmed their equal weight rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $80.00 price ...

Anticipated growth for ‘Saudi Arabia Thrombectomy Devices Market’ is significant from 2024 to 2032. The market showed steady growth in 2024 and is expected to continue rising due to strategies adopted ...